Journal of the American Society of Nephrology (JASN) podcast

SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade

0:00
21:23
Manda indietro di 15 secondi
Manda avanti di 15 secondi
Dr. Briggs and Brendon Neuen discuss his paper in the December issue of JASN. This article on the CREDENCE and EMPA-CKD clinical trials shows that SGLT2 inhibitors allow more consistent use of RAS blockade in patients with declining renal function.

Altri episodi di "Journal of the American Society of Nephrology (JASN)"